Applications for phase three of the Pathway Transformation Fund (PTF) are now open.
The fund supports NHS organisations increase their adoption of the 2020/21 Rapid Uptake Products RUPs, which are:
- Lipid Management: High Intensity Statins, Ezetimibe and PCSK9 inhibitors
- Measuring fractional exhaled nitric oxide (FeNO) concentration in asthma: products NIOX VERO and NObreath
- Biologics for treating severe asthma: Reslizumab, Benralizumab, Mepolizumab and Omalizumab
The PTF can help providers overcome practical obstacles to introducing these products, such as:
- Support set-up costs such as training and accreditation of staff;
- Pathway redesign and/or business support expertise;
- Providing funding for specialist nurses and clinical staff needed to implement a new part of the procedure; and
- Covering double running costs
- Capital costs.
NHS organisations will be able to submit applications for PTF until 12 noon, 30 April 2021. Applications should be developed and submitted with the support of your local AHSN RUP lead – please email info@innovationagencynwc.nhs.uk for further details.
News and blogs >
Research and innovation awards launched Read more
The search is under way for the best researchers and innovators in our region with the launch of the North West Coast Research and Innovation Awards 2025.
Care bundle boosts outcomes for babies Read more
More than 5,000 interventions a year are being carried out in the North West as part of a programme to improve outcomes for babies and families.
Maternity and neonatal team wins national award Read more
Health Innovation North West Coast’s maternity and neonatal experts are part of a team that won a prestigious award for perinatal care.
Showcasing the UK market and beautiful Liverpool to international innovators Read more
There are a number of exciting companies in Estonia and Ireland that I met at a recent brokerage event, and I look forward to continuing discussions and exploring opportunities to collaborate.